UPC CFI LD Paris, 13 March 2024: No extension of time limit for Statement of defence after intervention

IPPT20240313, UPC CFI, LD Paris, Laser Components v Seoul Viosys

UPC CoA, 11 March 2024: Leave to amend case by adding new patent requires same time for Statement of defense as in a new case

IPPT20240219, UPC CoA, Netgear v Huawei

UPC CFI LD Mannheidm, 22 February 2024: Request for joint hearing of revocation and infringement actions rejected

IPPT20240222, UPC CFI, LD Mannheim, MED-EL v Advanced Bionics

UPC CFI LD Paris, 27 February 2024: No change of language to English because Korean company opted for French, respectful of rights of the French defendant

IPPT20240227, UPC CFI, LD Paris, Seoul Viosys v Laser Components

UPC CFI LD Paris, 28 February 2024: Service of Statement of claim by alternative method on UK defendants is good service

IPPT20240228, UPC CFI, LD Paris, ICPillar v ARM

UPC CFI LD Düsseldorf, 1 March 2024: Request for simultaneaous interpretation rejected

IPPT20240301, UPC CFI, LD Düsseldorf, 10x Genomics v Curio Bioscience

UPC CFI LD Düsseldorf, 11 March 2024: Membership Rules Confidentiality Club

IPPT20240311, UPC CFI, LD Düsseldorf, 10x Genomics v Curio Bioscience

Priority for Community Design applications for six months, but not any more

IPPT20240227, CJEU, EUIPO v KaiKai

Vice-President decision: Online advertising: Amazon’s request to suspend its obligation to make an advertisement repository publicly available is rejected

IEPT20240327, VP CJEU, Commission v Amazon

UPC CFI CD Paris, 20 February 2024: No extension of deadline - no objective impossibility or serious difficulty to meet deadline

IPPT20240220, UPC CFI, CD Paris, Roche Diabetes Care v Tandem Diabetes Care

UPC CFI LD Düsseldorf, 21 February 2024: Time limit for filing counterclaim for revocation retrospectively extended with 1 day

IPPT20240221, UPC CFI, LD Düsseldorf, Fujifilm v Kodak

UPC CFI LD Düsseldorf, 23 February 2024: Restricted access group must have at least one natural person from a party

IPPT20240223, UPC CFI, LD Düsseldorf, 10x Genomics v Curio Bioscience